ZURA (STOCKS)
Zura Bio Limited Class A Ordinary Shares
$3.680000
-0.020000 (-0.54%)
Prev close: $3.700000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Sandeep C. Kulkarni
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $350.54M
- Employees
- 30
- P/E (TTM)
- -3.02
- P/B (TTM)
- 1.62
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.22 | $-0.18 | -0.0425 | -23.94% |
|
Dec 2025 (Q4)
|
$-0.49 | $-0.20 | -0.2896 | -144.51% |
|
Sep 2025 (Q3)
|
$-0.21 | $-0.19 | -0.0249 | -13.45% |
|
Jun 2025 (Q2)
|
$-0.17 | $-0.19 | +0.0221 | +11.50% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $6.06M |
| Operating Expenses | $81.49M |
| Research and Development | $46.35M |
| Other Operating Expenses | $35.14M |
| Operating Income/Loss | -$81.49M |
| Income/Loss From Continuing Operations After Tax | -$75.43M |
| Income/Loss From Continuing Operations Before Tax | -$75.43M |
| Net Income/Loss | -$75.43M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$75.43M |
| Net Income/Loss Available To Common Stockholders, Basic | -$106.13M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $30.70M |
| Preferred Stock Dividends And Other Adjustments | $30.70M |
| Basic Earnings Per Share | -$1.09 |
| Diluted Earnings Per Share | -$1.09 |
| Basic Average Shares | 301,295,838 |
| Diluted Average Shares | 301,295,838 |
| Assets | $228.64M |
| Current Assets | $227.00M |
| Noncurrent Assets | $1.64M |
| Fixed Assets | $125.00K |
| Other Non-current Assets | $1.51M |
| Liabilities | $11.75M |
| Current Liabilities | $11.75M |
| Accounts Payable | $2.08M |
| Other Current Liabilities | $9.66M |
| Noncurrent Liabilities | $0.00 |
| Equity | $216.90M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $216.90M |
| Temporary Equity | $0.00 |
| Liabilities And Equity | $228.64M |
| Net Cash Flow From Operating Activities | -$72.68M |
| Net Cash Flow From Operating Activities, Continuing | -$72.68M |
| Net Cash Flow From Investing Activities | -$77.00K |
| Net Cash Flow From Investing Activities, Continuing | -$77.00K |
| Net Cash Flow From Financing Activities | $127.78M |
| Net Cash Flow From Financing Activities, Continuing | $127.78M |
| Net Cash Flow | $55.03M |
| Net Cash Flow, Continuing | $55.03M |
| Comprehensive Income/Loss | -$75.43M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$75.43M |
| Other Comprehensive Income/Loss | $0.00 |